All In MedTech

FDA Clearance Tracker · K240582

VEA Align; spineEOS

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jun 25, 2024 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jun 25, 2024

Substantially Equivalent

Time to decision

116 days

Received Mar 1, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K240582
Device name
VEA Align; spineEOS
Applicant
Eos Imaging
Applicant location
Paris, FR
Received
Mar 1, 2024
Decided
Jun 25, 2024
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 892.2050

Every decision under product code QIH

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • We could not check whether this was the first decision under its product code.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Eos Imaging

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.